Palmezano-Díaz JM, Figueroa-Pineda CL, Rodríguez-Amaya RM, Plazas-Rey LK

Language: Spanish
References: 12
Page: 522-535
PDF size: 318.22 Kb.

ABSTRACT

Background: Autoimmune diseases affect around 3-5% of human beings, especially women. Due to its low prevalence, local clinical data on the behavior of this disease are unknown.
Objective: To find the prevalence of autoimmune diseases in the University Hospital of Santander, as well as to carry out the clinical and sociodemographic characterization of the diseases.
Material and Method: An observational, descriptive and retrospective crosssectional study on the prevalence of autoimmune diseases was done at the University Hospital of Santander between 2012 and 2016 in patients over 13 years of age who entered to the institution.
Results: A total of 1463 autoimmune diseases were found, with a prevalence of 378 cases per 100,000 patients over 13 years of age treated at the University Hospital of Santander and the population with autoimmune disease was 0.4%. The most prevalent diseases were rheumatoid arthritis, psoriasis, Graves’ disease, immune thrombocytopenic purpura and systemic lupus erythematosus and the most affected organs were the skin, thyroid gland, hematology system, pancreas and nervous system.
Conclusions: The data suggest that the prevalence in our environment is similar to that of studies in other populations; however, these prevalences are multifactorial and may vary among different populations.

REFERENCES

1. Rose NR. Las enfermedades autoinmunes: el rastreo de los hilos compartidos. Hosp Pract (1995) 1997;32:147.

2. Davidson AB. Diamond enfermedades autoinmunes. N Engl J Med 2001;345:340.

3. Arbuckle MR, McClain MT, Rubertone MV, et al. Desarrollo de autoanticuerpos antes de la aparición clínica de lupus eritematoso sistémico. N Engl J Med 2003;349:1526.

4. Rose NR. Los predictores de enfermedad autoinmune: autoanticuerpos y más allá. Autoinmunidad 2008;41:419.

5. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003;2(3):119-25.

6. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol [Internet]. 1997;84(3):223-43. Available from: http://linkinghub.elsevier.com/retrieve/pii/ S0090122997944123

7. Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology [Internet]. 2017;1-17. Available from: http://academic.oup.com/rheumatology/article/ doi/10.1093/rheumatology/kex260/4079913/The-worldwide- incidence-and-prevalence-of-systemic.

8. Nasonov E, Soloviev S, Davidson J, Lila A, Ivanova R, Togizbayev G, et al. The prevalence and incidence of systemic lupus erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan). Lupus [Internet]. 2014;23(2):213-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24255073.

9. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006;36(3):182-8.

10. Abraham-Nordling M, Byström K, Törring O, Lantz M, Berg G, Calissendorff J, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 2011;165(6):899-905.

11. Diagne N, Faye A, Ndao AC, Djiba B, Kane BS, Ndongo S, et al. Aspects épidémiologique, clinique, thérapeutique et évolutif de la maladie de Basedow en Médecine Interne au CHU Ledantec Dakar (Sénégal). Pan Afr Med J [Internet] 2016;25:1-5. Available from: http://www.panafrican-medjournal. com/content/article/25/6/full/

12. McKee A, Peyerl F. TSI assay utilization: Impact on costs of Graves’ hyperthyroidism diagnosis. Am J Manag Care 2012;18(1):1-14.